News

CorVue is a cardiac pharmacologic stress SPECT (single-photon-emission computed tomographic) imaging agent intended for use in patients with or at risk for coronary artery disease (CAD) who are

Additionally, former chairman of Respironics, Gerald McGinnis, has committed to provide up to $1.8 million in the form of convertible debt for bridge funding, to allow the company

SurgiLance safety lancets are also used in point-of-care diagnostic testing, including diabetes testing and testing for HIV, said MediPurpose. Smiths Medical was recently named as exclusive distributor for

The management team plans to deploy the capital from this first closing for initial product acquisitions that are already well advanced in the negotiation and due diligence process,

The offer will now expire on January 9, 2009, unless further extended or earlier terminated. The tender offer was extended to comply with a continuing order issued by

The tender offer was originally scheduled to expire on December 23, 2008. All other terms and conditions of the tender offer remain unchanged. As previously disclosed, the conditions

EXACT’s total revenues increased due to strategic relationship with Genzyme Corp. Exact in January entered into an intellectual property transaction with Genzyme that generated $17.2 million in cash.

Under the terms of the agreement, GlaxoSmithKline (GSK) is expected to pay Ligand $5m as an upfront license fee, up to $158m in development and commercial milestones and a 16%

With this transaction, Radi Medical Systems will become part of the St Jude Medical cardiovascular division. The transaction is expected to be neutral to St Jude Medical’s consolidated